{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:41:14Z","timestamp":1788972074775,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:00:00Z","timestamp":1511222400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior(CAPES)"},{"name":"Programa de Apoio aos N\u00facleos de Excel\u00eancia (PRONEX)"},{"name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Estado de Santa Catarina(FAPESC)"},{"name":"Financiadora de Estudos e Projetos (FINEP)","award":["01.06.0842-00"],"award-info":[{"award-number":["01.06.0842-00"]}]},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia (INCT)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12640-017-9840-8","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T03:55:09Z","timestamp":1511236509000},"page":"549-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Atorvastatin Prevents Early Oxidative Events and Modulates Inflammatory Mediators in the Striatum Following Intranasal 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Administration in Rats"],"prefix":"10.1007","volume":"33","author":[{"given":"Naiani F.","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalberto A.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda L.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adair R. S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui D.","family":"Prediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreza Fabro","family":"De Bem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla I.","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"issue":"1","key":"9840_CR1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pneurobio.2007.10.003","volume":"84","author":"H Allain","year":"2008","unstructured":"Allain H, Bentu\u00e9-Ferrer D, Akwa Y (2008) Disease-modifying drugs and Parkinson\u2019s disease. Prog Neurobiol 84(1):25\u201339","journal-title":"Prog Neurobiol"},{"issue":"5","key":"9840_CR2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35072550","volume":"2","author":"MF Beal","year":"2001","unstructured":"Beal MF (2001) Experimental models of Parkinson\u2019s disease. Nat Rev Neurosci 2(5):325\u2013334","journal-title":"Nat Rev Neurosci"},{"key":"9840_CR3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"9840_CR4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0076-6879(85)13062-4","volume":"113","author":"I Carlberg","year":"1985","unstructured":"Carlberg I, Mannervik B (1985) Glutathione reductase. Methods Enzymol 113:484\u2013490","journal-title":"Methods Enzymol"},{"issue":"2","key":"9840_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/abbi.1996.0178","volume":"328","author":"A Cassina","year":"1996","unstructured":"Cassina A, Radi R (1996) Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 328(2):309\u2013316","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"9840_CR6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2012.01.016","volume":"229","author":"AA Castro","year":"2012","unstructured":"Castro AA, Ghisoni K, Latini A, Quevedo J, Tasca CI, Prediger RD (2012) Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson\u2019s disease. Behav Brain Res 229(1):208\u2013215","journal-title":"Behav Brain Res"},{"key":"9840_CR7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2013.03.029","volume":"1513","author":"AA Castro","year":"2013","unstructured":"Castro AA, Wiemes BP, Matheus FC, Lapa FR, Viola GG, Santos AR, Tasca CI, Prediger RD (2013) Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson\u2019s disease. Brain Res 1513:103\u2013116","journal-title":"Brain Res"},{"issue":"6","key":"9840_CR8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM Lau de","year":"2006","unstructured":"de Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5(6):525\u2013535","journal-title":"Lancet Neurol"},{"key":"9840_CR9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","volume":"62","author":"DT Dexter","year":"2013","unstructured":"Dexter DT, Jenner P (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 62:132\u2013144","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"9840_CR10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neulet.2011.12.054","volume":"509","author":"Y Du","year":"2012","unstructured":"Du Y, Zhang X et al (2012) Probucol and atorvastatin in combination protect rat brains in MCAO model: upregulating peroxiredoxin2, Foxo3a and Nrf2 expression. Neurosci Lett 509(2):110\u2013115","journal-title":"Neurosci Lett"},{"issue":"1","key":"9840_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0009-8981(85)90135-4","volume":"153","author":"JC Fischer","year":"1985","unstructured":"Fischer JC, Ruitenbeek W, Berden JA, Trijbels JM, Veerkamp JH, Stadhouders AM, Sengers RC, Janssen AJ (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 153(1):23\u201336","journal-title":"Clin Chim Acta"},{"issue":"20","key":"9840_CR12","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.lfs.2007.02.021","volume":"80","author":"J Franco","year":"2007","unstructured":"Franco J, Prediger RD, Pandolfo P, Takahashi RN, Farina M, Dafre AL (2007) Antioxidant responses and lipid peroxidation following intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats: increased susceptibility of olfactory bulb. Life Sci 80(20):1906\u20131914","journal-title":"Life Sci"},{"issue":"8","key":"9840_CR13","first-page":"626","volume":"19","author":"B Friedman","year":"2013","unstructured":"Friedman B, Lahad A, Dresner Y, Vinker S (2013) Long-term statin use and the risk of Parkinson\u2019s disease. Am J Manag Care 19(8):626\u2013632","journal-title":"Am J Manag Care"},{"issue":"3","key":"9840_CR14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archneurol.2011.1060","volume":"69","author":"X Gao","year":"2012","unstructured":"Gao X, Simon KC, Schwarzschild MA, Ascherio A (2012) Prospective study of statin use and risk of Parkinson disease. Arch Neurol 69(3):380\u2013384","journal-title":"Arch Neurol"},{"issue":"43","key":"9840_CR15","doi-asserted-by":"crossref","first-page":"13543","DOI":"10.1523\/JNEUROSCI.4144-09.2009","volume":"29","author":"A Ghosh","year":"2009","unstructured":"Ghosh A, Roy A, Matras J, Brahmachari S, Gendelman HE, Pahan K (2009) Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson\u2019s disease. J Neurosci 29(43):13543\u201313556","journal-title":"J Neurosci"},{"issue":"1","key":"9840_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/abbi.1996.9726","volume":"337","author":"E Hasegawa","year":"1997","unstructured":"Hasegawa E, Kang D, Sakamoto K, Mitsumoto A, Nagano T, Minakami S, Takeshige K (1997) A dual effect of 1-methyl-4-phenylpyridinium (MPP+)-analogs on the respiratory chain of bovine heart mitochondria. Arch Biochem Biophys 337(1):69\u201374","journal-title":"Arch Biochem Biophys"},{"issue":"1\u20132","key":"9840_CR17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0891-5849(99)00061-1","volume":"27","author":"SL Hempel","year":"1999","unstructured":"Hempel SL, Buettner GR, O\u2019Malley YQ, Wessels DA, Flaherty DM (1999) Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2\u2032,7\u2032-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2\u2032,7\u2032-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic Biol Med 27(1\u20132):146\u2013159","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"9840_CR18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1471-4159.2007.05148.x","volume":"105","author":"MC Hern\u00e1ndez-Romero","year":"2008","unstructured":"Hern\u00e1ndez-Romero MC, Arg\u00fcelles S, Villar\u00e1n RF, de Pablos RM, Delgado-Cort\u00e9s MJ, Santiago M, Herrera AJ, Cano J, Machado A (2008) Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide. J Neurochem 105(2):445\u2013459","journal-title":"J Neurochem"},{"issue":"6180","key":"9840_CR19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E Hirsch","year":"1988","unstructured":"Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature 334(6180):345\u2013348","journal-title":"Nature"},{"issue":"1","key":"9840_CR20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0003-2697(76)90326-2","volume":"74","author":"PJ Hissin","year":"1976","unstructured":"Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74(1):214\u2013226","journal-title":"Anal Biochem"},{"issue":"1","key":"9840_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12640-013-9449-5","volume":"25","author":"H Kadar","year":"2014","unstructured":"Kadar H, Le Douaron G et al (2014) MALDI mass spectrometry imaging of 1-methyl-4-phenylpyridinium (MPP+) in mouse brain. Neurotox Res 25(1):135\u2013145","journal-title":"Neurotox Res"},{"key":"9840_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2012.06.050","volume":"1471","author":"A Kumar","year":"2012","unstructured":"Kumar A, Sharma N, Gupta A, Kalonia H, Mishra J (2012) Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms. Brain Res 1471:13\u201322","journal-title":"Brain Res"},{"issue":"1\u20132","key":"9840_CR23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ymgme.2005.05.002","volume":"86","author":"A Latini","year":"2005","unstructured":"Latini A, da Silva CG, Ferreira GC, Schuck PF, Scussiato K, Sarkis JJ, Dutra Filho CS, Wyse AT, Wannmacher CM, Wajner M (2005) Mitochondrial energy metabolism is markedly impaired by D-2-hydroxyglutaric acid in rat tissues. Mol Genet Metab 86(1\u20132):188\u2013199","journal-title":"Mol Genet Metab"},{"issue":"12","key":"9840_CR24","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","volume":"5","author":"GT Liberatore","year":"1999","unstructured":"Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5(12):1403\u20131409","journal-title":"Nat Med"},{"issue":"5","key":"9840_CR25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1021\/cn500275k","volume":"6","author":"CM Lin","year":"2015","unstructured":"Lin CM, Lin YT, Lin RD, Huang WJ, Lee MH (2015) Neurocytoprotective effects of aliphatic hydroxamates from lovastatin, a secondary metabolite from monascus-fermented red mold rice, in 6-hydroxydopamine (6-OHDA)-treated nerve growth factor (NGF)-differentiated PC12 cells. ACS Chem Neurosci 6(5):716\u2013724","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"9840_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265\u2013275","journal-title":"J Biol Chem"},{"key":"9840_CR27","doi-asserted-by":"crossref","unstructured":"Ludka FK, Cunha MP, Dal-Cim T, Binder LB, Constantino LC, Massari CM, Martins WC, Rodrigues AL, Tasca CI (2016) Atorvastatin protects from A\u03b21-40-induced cell damage and depressive-like behavior via ProBDNF cleavage. Mol Neurobiol","DOI":"10.1007\/s12035-016-0134-6"},{"issue":"5","key":"9840_CR28","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s12035-016-9882-6","volume":"54","author":"FK Ludka","year":"2017","unstructured":"Ludka FK, Dal-Cim T, Binder LB, Constantino LC, Massari C, Tasca CI (2017) Atorvastatin and fluoxetine prevent oxidative stress and mitochondrial dysfunction evoked by glutamate toxicity in hippocampal slices. Mol Neurobiol 54(5):3149\u20133161","journal-title":"Mol Neurobiol"},{"key":"9840_CR29","doi-asserted-by":"crossref","unstructured":"Martins WC, dos Santos VV, dos Santos AA, Vandresen-Filho S, Dal-Cim TA, de Oliveira KA, Mendes-de-Aguiar CB, Farina M, Prediger RD, Viola GG, Tasca CI (2015) Atorvastatin prevents cognitive deficits induced by intracerebroventricular amyloid-\u03b21-40 administration in mice: involvement of glutamatergic and antioxidant systems. Neurotox Res 28(1): 32\u201342","DOI":"10.1007\/s12640-015-9527-y"},{"issue":"2","key":"9840_CR30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbr.2012.08.017","volume":"235","author":"FC Matheus","year":"2012","unstructured":"Matheus FC, Aguiar AS, Castro AA, Villarinho JG, Ferreira J, Figueiredo CP, Walz R, Santos AR, Tasca CI, Prediger RD (2012) Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Behav Brain Res 235(2):263\u2013272","journal-title":"Behav Brain Res"},{"issue":"2","key":"9840_CR31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mehy.2006.01.013","volume":"67","author":"MF McCarty","year":"2006","unstructured":"McCarty MF (2006) Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders. Med Hypotheses 67(2):251\u2013269","journal-title":"Med Hypotheses"},{"issue":"8","key":"9840_CR32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38(8):1285\u20131291","journal-title":"Neurology"},{"issue":"2","key":"9840_CR33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","volume":"180","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T (1994) Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 180(2):147\u2013150","journal-title":"Neurosci Lett"},{"key":"9840_CR34","doi-asserted-by":"crossref","unstructured":"Moreira EL, Rial D, Aguiar AS, Figueiredo CP, Siqueira JM, DalB\u00f3 S, Horst H, de Oliveira J, Mancini G, dos Santos TS, Villarinho JG, Pinheiro FV, Marino-Neto J, Ferreira J, De Bem AF, Latini A, Pizzolatti MG, Ribeiro-do-Valle RM, Prediger RD (2010) Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson\u2019s disease. J Neural Transm (Vienna) 117(12): 1337\u20131351","DOI":"10.1007\/s00702-010-0464-x"},{"key":"9840_CR35","doi-asserted-by":"crossref","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari A (2000a) Changes in cytokines and neurotrophins in Parkinson\u2019s disease. J Neural Transm Suppl (60):277\u2013290","DOI":"10.1007\/978-3-7091-6301-6_19"},{"key":"9840_CR36","first-page":"143","volume":"58","author":"T Nagatsu","year":"2000","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari A (2000b) Cytokines in Parkinson\u2019s disease. J Neural Transm Suppl 58:143\u2013151","journal-title":"J Neural Transm Suppl"},{"issue":"2","key":"9840_CR37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2010.08.030","volume":"226","author":"TC Piermartiri","year":"2010","unstructured":"Piermartiri TC, Figueiredo CP, Rial D, Duarte FS, Bezerra SC, Mancini G, de Bem AF, Prediger RD, Tasca CI (2010) Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-\u03b2(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage. Exp Neurol 226(2):274\u2013284","journal-title":"Exp Neurol"},{"issue":"2","key":"9840_CR38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12640-009-9057-6","volume":"16","author":"TC Piermartiri","year":"2009","unstructured":"Piermartiri TC, Vandresen-Filho S, de Ara\u00fajo Herculano B, Martins WC, Dal\u2019agnolo D, Stroeh E, Carqueja CL, Boeck CR, Tasca CI (2009) Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake. Neurotox Res 16(2):106\u2013115","journal-title":"Neurotox Res"},{"issue":"5","key":"9840_CR39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2174\/138161211795164095","volume":"17","author":"RD Prediger","year":"2011","unstructured":"Prediger RD, Aguiar AS, Moreira EL, Matheus FC, Castro AA, Walz R, De Bem AF, Latini A, Tasca CI, Farina M, Raisman-Vozari R (2011) The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson\u2019s disease. Curr Pharm Des 17(5):489\u2013507","journal-title":"Curr Pharm Des"},{"issue":"2","key":"9840_CR40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","volume":"17","author":"RD Prediger","year":"2010","unstructured":"Prediger RD, Aguiar AS, Rojas-Mayorquin AE, Figueiredo CP, Matheus FC, Ginestet L, Chevarin C, Bel ED, Mongeau R, Hamon M, Lanfumey L, Raisman-Vozari R (2010) Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson\u2019s disease. Neurotox Res 17(2):114\u2013129","journal-title":"Neurotox Res"},{"issue":"2","key":"9840_CR41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.expneurol.2006.07.001","volume":"202","author":"RD Prediger","year":"2006","unstructured":"Prediger RD, Batista LC, Medeiros R, Pandolfo P, Florio JC, Takahashi RN (2006) The risk is in the air: intranasal administration of MPTP to rats reproducing clinical features of Parkinson\u2019s disease. Exp Neurol 202(2):391\u2013403","journal-title":"Exp Neurol"},{"key":"9840_CR42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1749-6632.2009.03885.x","volume":"1170","author":"RD Prediger","year":"2009","unstructured":"Prediger RD, Rial D, Medeiros R, Figueiredo CP, Doty RL, Takahashi RN (2009) Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) rat model of Parkinson\u2019s disease. Ann N Y Acad Sci 1170:629\u2013636","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"9840_CR43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/B:JOBB.0000041771.66775.d5","volume":"36","author":"S Przedborski","year":"2004","unstructured":"Przedborski S, Tieu K, Perier C, Vila M (2004) MPTP as a mitochondrial neurotoxic model of Parkinson\u2019s disease. J Bioenerg Biomembr 36(4):375\u2013379","journal-title":"J Bioenerg Biomembr"},{"issue":"3","key":"9840_CR44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/syn.21881","volume":"70","author":"M Schmitt","year":"2016","unstructured":"Schmitt M, Dehay B, Bezard E, Garcia-Ladona FJ (2016) Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line. Synapse 70(3):71\u201386","journal-title":"Synapse"},{"issue":"1\u20132","key":"9840_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2004.02.083","volume":"1037","author":"ML Selley","year":"2005","unstructured":"Selley ML (2005) Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice. Brain Res 1037(1\u20132):1\u20136","journal-title":"Brain Res"},{"issue":"11","key":"9840_CR46","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","volume":"16","author":"K Sriram","year":"2002","unstructured":"Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O\u2019Callaghan JP (2002) Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson\u2019s disease. FASEB J 16(11):1474\u20131476","journal-title":"FASEB J"},{"issue":"7","key":"9840_CR47","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.neuint.2013.03.002","volume":"62","author":"S Vandresen-Filho","year":"2013","unstructured":"Vandresen-Filho S, Martins WC, Bertoldo DB, Mancini G, Herculano BA, de Bem AF, Tasca CI (2013) Atorvastatin prevents cell damage via modulation of oxidative stress, glutamate uptake and glutamine synthetase activity in hippocampal slices subjected to oxygen\/glucose deprivation. Neurochem Int 62(7):948\u2013955","journal-title":"Neurochem Int"},{"issue":"1","key":"9840_CR48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbr.2009.11.006","volume":"208","author":"AL Wang","year":"2010","unstructured":"Wang AL, Liou YM, Pawlak CR, Ho YJ (2010) Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats. Behav Brain Res 208(1):38\u201346","journal-title":"Behav Brain Res"},{"issue":"1","key":"9840_CR49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.expneurol.2010.04.006","volume":"230","author":"Q Wang","year":"2011","unstructured":"Wang Q, Yan J, Chen X, Li J, Yang Y, Weng J, Deng C, Yenari MA (2011) Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp Neurol 230(1):27\u201334","journal-title":"Exp Neurol"},{"issue":"6","key":"9840_CR50","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1037\/a0017401","volume":"123","author":"WF Wang","year":"2009","unstructured":"Wang WF, SL W, Liou YM, Wang AL, Pawlak CR, Ho YJ (2009) MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats. Behav Neurosci 123(6):1261\u20131270","journal-title":"Behav Neurosci"},{"key":"9840_CR51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0076-6879(81)77046-0","volume":"77","author":"A Wendel","year":"1981","unstructured":"Wendel A (1981) Glutathione peroxidase. Methods Enzymol 77:325\u2013333","journal-title":"Methods Enzymol"},{"issue":"6","key":"9840_CR52","volume":"6","author":"J Yan","year":"2011","unstructured":"Yan J, Xu Y, Zhu C, Zhang L, Wu A, Yang Y, Xiong Z, Deng C, Huang XF, Yenari MA, Yang YG, Ying W, Wang Q (2011) Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses. PLoS One 6(6):e20945","journal-title":"PLoS One"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-017-9840-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9840-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9840-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T19:04:22Z","timestamp":1659899062000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-017-9840-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["9840"],"URL":"https:\/\/doi.org\/10.1007\/s12640-017-9840-8","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]}}}